fda warning letter semaglutide october 2025 Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly Letter to FDA's Office of

As evidenced by our predictions in Fig

Common side effects during titration The most frequently reported side effects during the first weeks of tirzepatide use include nausea, which affects up to 30% of patients and typically peaks during dose increases

PlexusDx's personalized approach includes reviewing your full medical history to anticipate and minimize side effects from the start

Moderate nausea means it slowed you down or made you skip a meal

The mechanism linking semaglutide to migraines is not fully understood, but several biological pathways may be relevant

These include the dose of each medication, any pre-existing health conditions, and the overall health of the person taking them